Gossamer Bio Inc. (NASDAQ: GOSS) reported Q1 EPS of ($0.16), $0.03 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $9.89 million versus the consensus estimate of $4.25 million.

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.